OS Therapies OSTX Growth Metrics (2023-2026)

NYSE OSTX
$1.27 +0.01 (+1.19%)
As of: Oct 21, 2026 · 2:24 PM EDT
Reported Financials

OS Therapies Quarterly Growth Metrics

Periods 13 quarters
Latest Jun 2026

OS Therapies reported asset growth of -4.01% for the quarter ended Jun 2026. These growth metrics cover 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 594.01%305.17%668.17%352.81%23.48%71.75%-4.01%
Assets (QoQ) 31.43%27.96%47.31%180.12%-23.27%142.60%-13.16%-23.61%6.72%35.59%
Capital Expenditures (QoQ)Capex (QoQ) 110.95%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -71.78%92.85%11,470.48%14,095.08%2,864.16%2,851.82%1.00%-95.12%-69.12%-92.68%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 37.21%60.90%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -86.14%-67.37%142.74%157.12%-5.29%1,857.44%197.81%-46.31%-5.69%-33.03%-85.62%240.05%-77.65%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -101.66%-68.62%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -49.87%-6.03%-286.14%-172.58%-436.35%-167.85%-39.04%-57.09%-33.65%-133.03%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) -120.65%-87.75%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -94.09%-5.48%0.62%26.34%-37.32%-284.12%29.85%-44.95%31.43%-99.39%20.74%-23.32%-19.57%
Dividends payables Growth (1y) 1,100.00%9.09%0.00%0.00%0.00%0.00%0.00%0.00%
Dividends payables Growth (3y) 128.94%
Dividends payables (QoQ) 9.09%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT Growth (1y) 39.87%48.54%-291.73%-156.38%-693.28%-520.51%-182.25%-304.12%-103.38%-77.23%
EBIT Growth (3y) -113.28%-78.20%
EBIT (QoQ) -44.59%58.94%-85.96%45.53%-23.73%-212.57%-21.70%-68.54%3.22%-42.18%-74.25%15.18%15.66%
EBT Growth (1y) 21.01%37.83%-45.58%-103.06%-242.66%-210.67%-139.27%-303.09%-104.89%-77.35%
EBT Growth (3y) -77.01%-50.74%
EBT (QoQ) -35.63%21.16%25.84%0.38%-6.75%-84.61%-3.43%-68.11%3.22%-42.18%-74.25%14.55%16.23%
EPS (Basic) Growth (1y) 28.98%45.27%51.86%12.28%-19.91%-265.49%-696.66%-1,066.56%-595.19%-90.28%
EPS (Basic) Growth (3y) -80.91%-56.14%
EPS (Basic) (QoQ) -29.14%20.90%26.67%5.19%0.48%30.43%-33.62%-29.61%-203.35%-51.64%-95.67%22.76%16.97%
EPS (Diluted) Growth (1y) 45.27%51.86%-53.65%26.65%30.52%-19.03%-6.91%-47.35%-8.85%
EPS (Diluted) Growth (3y) 25.47%
EPS (Diluted) (QoQ) 20.90%25.44%11.20%-4.51%30.43%-137.97%57.61%0.99%-19.18%-113.75%41.58%26.86%
Free Cash Flow Growth (1y)FCF Growth (1y) -49.87%-6.03%-286.14%-172.58%-459.72%-203.76%-39.04%-57.09%-28.07%-105.48%
Free Cash Flow Growth (3y)FCF Growth (3y) -120.65%-87.75%
Free Cash Flow (QoQ)FCF (QoQ) -94.09%-5.48%0.62%26.34%-37.32%-284.12%29.85%-51.26%25.48%-75.82%20.74%-23.32%-19.57%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) 42.03%34.51%-1,110.33%-10,334.92%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) -368.57%-901.18%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -16.72%69.96%-717.98%79.79%-31.86%-455.17%-6,952.29%-1,038.59%
Net Cash Flow Growth (1y)NCF Growth (1y) -66.66%98.27%5,416.71%15,933.78%-4,283.77%-3,084.96%-152.48%-143.72%123.85%-302.17%
Net Cash Flow Growth (3y)NCF Growth (3y) 49.28%-30.47%
Net Cash Flow (QoQ)NCF (QoQ) -266.54%89.16%169.12%167.19%-108.66%33,329.91%108.45%-169.72%93.41%-447.59%-73.64%138.04%-211.19%
Net Income Growth (1y) 21.01%37.83%-45.58%-104.24%-165.72%-191.28%-139.27%-351.55%-168.18%-90.28%
Net Income Growth (3y) -77.89%-51.04%
Net Income (QoQ) -35.63%21.16%25.84%0.38%-6.75%-84.61%-4.03%-29.61%-17.02%-51.64%-96.34%23.03%16.97%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 20.66%38.59%-43.31%-99.97%-160.15%-191.28%-139.27%-350.01%-168.18%-90.28%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -76.90%-50.42%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -35.04%20.90%25.44%0.37%-4.51%-84.61%-4.03%-29.61%-17.02%-51.64%-95.67%22.76%16.97%
Operating Income Growth (1y)Op. Inc Growth (1y) 39.87%48.54%-291.73%-156.38%-693.28%-520.51%-182.25%-304.12%-103.38%-77.23%
Operating Income Growth (3y)Op. Inc Growth (3y) -113.28%-78.20%
Operating Income (QoQ)Op. Inc (QoQ) -44.59%58.94%-85.96%45.53%-23.73%-212.57%-21.70%-68.54%3.22%-42.18%-74.25%15.18%15.66%
Profit After Tax Growth (1y)PAT Growth (1y) 21.01%37.83%-45.58%-103.06%-242.66%-210.67%-139.27%-303.09%-104.89%-77.35%
Profit After Tax Growth (3y)PAT Growth (3y) -77.01%-50.74%
Profit After Tax (QoQ)PAT (QoQ) -35.63%21.16%25.84%0.38%-6.75%-84.61%-3.43%-68.11%3.22%-42.18%-74.25%14.55%16.23%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -34.53%-41.74%-52.18%-52.75%-60.77%-71.65%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 0.00%-20.87%-13.19%-15.19%-17.91%-21.82%-27.91%-38.72%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.05M0.03M0.02M-0.01M-0.02M-0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.03M0.01M0.02M0.00M0.00M0.00M-0.02M-0.01M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.04M0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.37M
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 498.05%52.49%47.05%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 250.83%-3.84%-9.97%96.90%-10.54%-7.26%
Total Debt (QoQ) 6.64%-5.88%

OS Therapies Growth Metrics API

Pull OS Therapies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OSTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY